Fixed Price IPO | ₹2 Cr | Listed at BSE SME | Fri, Jan 29, 2016 - Tue, Feb 9, 2016
Ganga Pharmaceuticals IPO is a fixed price issue of ₹1.54 crores. The issue is entirely a fresh issue of 0.10 crore shares of ₹1.54 crore.
Ganga Pharmaceuticals IPO bidding started from Jan 29, 2016 and ended on Feb 9, 2016. The shares got listed on BSE SME on Feb 22, 2016.
Ganga Pharmaceuticals IPO price is ₹15 per share. The lot size for an application is 8,000. The minimum amount of investment required by an individual investor (retail) is ₹1,20,000 (8000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (16,000 shares), amounting to ₹2,40,000.
First Overseas Capital Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Alacrity Securities Ltd..
Refer to Ganga Pharmaceuticals IPO RHP for detailed Information.
IPO Open
Fri, Jan 29, 2016
IPO Close
Tue, Feb 9, 2016
Issue Price
₹15 per share
Market Cap (Pre-IPO)
₹60.92 Cr
| IPO Date | 29 Jan to 9 Feb, 2016 |
| Listed on | Mon, Feb 22, 2016 |
| Face Value | ₹10 per share |
| Issue Price | ₹15 per share |
| Lot Size | 8,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 10,24,000 shares (agg. up to ₹2 Cr) |
| Fresh Issue | 10,24,000 shares (agg. up to ₹2 Cr) |
| Share Holding Pre Issue | 30,37,500 shares |
| Share Holding Post Issue | 4,06,15,000 shares |
| BSE Script Code | 539680 |
| ISIN | INE615T01017 |
Ganga Pharmaceuticals IPO comprises a total issue size of 10,24,000 shares. Out of which, 5,12,000 (50.00%) allocated to NII 5,12,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue |
|---|---|---|
| NII (HNI) Shares Offered | 5,12,000 | 50.00% |
| Retail Shares Offered | 5,12,000 | 50.00% |
| Total Shares Offered | 10,24,000 | 100.00% |
Investors can bid for a minimum of 8,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 8,000 | ₹1,20,000 |
| Retail (Max) | 1 | 8,000 | ₹1,20,000 |
| HNI (Min) | 2 | 16,000 | ₹2,40,000 |
Incorporated in 1994, Ganga Pharmaceuticals Ltd (GPL) is engaged in production of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines all over Maharashtra.
Company is manufacturing the following proprietary products:
1) Ampachan Vati;
2) Khadira Vati;
3) Nirmalaya churna
Company's products are available in liquid dosage form and solid dosage forms. Liquid dosage form includes Oil-based products and solid dosage forms includes Powder-based products, Tablets, and Pills.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Deployment of production capacity | 0.25 |
| 2 | Marketing and Brand Building | 0.70 |
| 3 | General Corporate Purpose | 0.30 |
| 4 | Issue Expenses | 0.29 |
| KPI | |
|---|---|
| RoNW | 1.27% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 91.05% | 68.09% |
| Market Cap | ₹60.92 Cr. |
Sorry, we couldn't find the subscription details. Note that the bidding starts at 10 AM and ends at 5 PM on the days when the public issue is open.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Issue management fees including fees and reimbursements of Market Making fees, selling commissions, brokerages, and payment to other intermediaries such as Legal Advisors, Registrars and other out of pocket expenses. | 0.15 |
| 2 | Printing & Stationery, Distribution, Postage, etc | 0.04 |
| 3 | Advertisement & Marketing Expenses | 0.02 |
| 4 | Regulatory & other expenses | 0.08 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹15.00 |
| Open | ₹14.50 |
| Low | ₹14.50 |
| High | ₹14.50 |
| Last Trade | ₹14.50 |
Lead Manager Reports
Ganga Pharmaceuticals IPO is a SME IPO of 10,24,000 equity shares of the face value of ₹10 aggregating up to ₹2 Crores. The issue is priced at ₹15 per share. The minimum order quantity is 8000.
The IPO opens on Fri, Jan 29, 2016, and closes on Tue, Feb 9, 2016.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Ganga Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Ganga Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Ganga Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Ganga Pharmaceuticals IPO opens on Fri, Jan 29, 2016 and closes on Tue, Feb 9, 2016.
Ganga Pharmaceuticals IPO lot size is 8000, and the minimum amount required for application is ₹1,20,000.
You can apply in Ganga Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Ganga Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Ganga Pharmaceuticals IPO allotment status.
The Ganga Pharmaceuticals IPO listing date is on Mon, Feb 22, 2016.
